You have 10 free articles left this month. Get your freeBasic subscription now and gain instant access to more.

Krka d.d.

Summary

Company ID (NIN)

5043611000

Company owner / manager

  • Kapitalska Druzba d.d.

Country

Slovenia

Capital

54,732,000

Total assets

1,916,065,000

Net profit for the period

163,329,000

Report year

2018

Currency

EUR

Industry

Pharmaceuticals

Southeastern Europe Company Index (SEECI)

What is SEECI?

General information

About Krka d.d.

Krka d.d. is a Slovenian pharmaceuticals producer.

As of June 2019, the company’s shares are included in Ljubljana Stock Exchange’s blue-chip index SBITOP.

The company has an:

  • ISO 9001:2015 Quality management systems certificate, valid until Nov 30, 2021;
  • OHSAS 18001:2007 Occupational health and safety management systems certificate, valid until Nov 30, 2020;
  • ISO 14001:2015 Environmental management systems certificate, valid until Nov 30, 2020;
  • ISO/IEC 27001:2013 Information security management systems certificate, valid until Nov 6, 2019.

 

Last updated on Aug 26, 2019.

Meta info
Status
Active
Legal form
Joint Stock Company
Incorporation date
July 13, 1989
NIN
5043611000
Tickers
KRKG
Stock Exchange
Ljubljana Stock Exchange
ISIN
SI0031102120
Profile last updated
Sept. 3, 2019, 9:27 a.m.
Alternative names

    Krka JSC
    Krka, Tovarna Zdravil, d.d., Novo mesto
    Krka d.d. Novo mesto
    Krka

History

    July 13, 1989 - Krka d.o.o. is established in Novo Mesto, southeastern Slovenia.

    Feb 10, 1997 - The company lists on the Ljubljana Stock Exchange market. Later Krka d.o.o. transforms into a joint stock company from a limited liability company.

    2007 - Krka d.d. acquires a 100% stake in Germany - based company TAD Pharma GmbH for EUR 97.0 mln.

    Nov 6, 2008 - The company buys 100% in Austria - based pharmaceutical manufacturer Alternova Arzneimittel GMBH for EUR 1.3 mln.


    Last updated on Aug 26, 2019.

Management

Board of Directors and Executives
Joze Colaric
Chairman of the Board and CEO
Vinko Zupancic
Member of the Board
Ales Rotar
Member of the Board
David Bratoz
Member of the Board
Milena Kastelic
Member of the Board
Supervisory Board
Joze Mermal
Chairman of the Board
Julijana Kristl
Member of the Board
Boris Znidaric
Member of the Board
Mojca Osolnik Videmsek
Member of the Board
Mateja Vrecer
Member of the Board
Franc Sasek
Deputy-Chairman of the Board
Andrej Slapar
Deputy-Chairman of the Board
Tomaz Sever
Member of the Board
Borut Jamnik
Member of the Board

Contacts

Address
6, Smarjeska Str.
8000
Novo Mesto, Slovenia
Telephones

+386 7 331 21 11

Fax

+386 7 332 15 37

Emails

info@krka.biz

Websites
www.krka.biz

Ownership

Name Direct holding Indirect holding Owner type Country
Kapitalska Druzba d.d. 10.65 Company Slovenia

Subsidiaries and affiliates

Name Direct holding Indirect holding Country
KRKA Belgium SA 95.0 Belgium
Farma GRS d.o.o. 99.7 Slovenia
KRKA Bulgaria EOOD 100.0 Bulgaria
Krka Pharma GmbH 100.0 Austria
Krka Farma d.o.o. 100.0 Bosnia and Herzegovina
UAB Krka Lietuva 100.0 Lithuania
Krka-Polska Sp. z o.o. 100.0 Poland
Krka Farmaceutica Unipessoal Lda. 100.0 Portugal
OOO KRKA-Rus 100.0 Russia
KRKA Slovensko s.r.o. 100.0 Slovakia
Krka UK Ltd 100.0 UK
Krka USA LLC 100.0 USA
Krka - Farma d.o.o. 100.0 Croatia
Krka-Farma DOO 100.0 Serbia
TOV Krka Ukraine 100.0 Ukraine
Terme Krka d.o.o. 100.0 Slovenia
Krka Romania SRL 100.0 Romania
OOO Krka Farma 100.0 Russia
Ningbo Krka Menovo Pharmaceutical Co. Ltd. 60.0 Japan
Krka France Eurl 100.0 France
TAD Pharma GmbH 100.0 Germany
Krka Pharma Dublin Limited 100.0 Ireland
Krka Farmaceutici Milano S.r.l. 100.0 Italy
Krka Farmaceutica S.L. 100.0 Spain
Krka Sverige AB 100.0 Sweden
Krka CR s.r.o. 100.0 Czech Republic
Krka Finland Oy 100.0 Finland
KRKA Magyarorszag Kft. 100.0 Hungary
TOO Krka Kazakhstan 100.0 Kazakhstan
SIA Krka Latvija 100.0 Latvia
Krka Farma d.o.o.e.l. 100.0 N. Macedonia

Products and services

Krka d.d.'s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products.

Prescription pharmaceuticals products for:

  • Cardiovascular diseases;
  • Diseases of alimentary tract and metabolism;
  • Diseases of central nervous system;
  • Infections;
  • Oncology.

Non-prescription products:

  • Products for the oral cavity and pharynx;
  • Cold and cough products;
  • Analgesic;
  • Nasal products;
  • Vitamin and mineral products;
  • Products for improving cerebral and peripheral circulation;
  • Products for the digestive tract and improving digestion;
  • Hair care products.

Animal health products:

  • Analgesics;
  • Antimicrobials;
  • Antiparasitics;
  • Disinfectants;
  • Vitamins and minerals.

Capacity

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Employment

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Market and sales

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Investment plans

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles

Financial information

Access 800,000+
basic

Basic profiles include:

  • General information
  • Contacts
  • Management
  • Ownership
  • Employment
  • Financial Information & Key Financial Ratios
and 4,000+
premium

Additionaly to the content in basic profiles, premium profiles include:

  • Company History
  • Subsidiaries & Affiliates
  • Product & Services
  • Capacity
  • Market & Sales
  • Investment Plans
company profiles
Compare